Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Express Scripts
AstraZeneca
Chinese Patent Office
Colorcon
Chubb
US Department of Justice
Fuji

Generated: April 21, 2018

DrugPatentWatch Database Preview

TARACTAN Drug Profile

« Back to Dashboard

When do Taractan patents expire, and what generic alternatives are available?

Taractan is a drug marketed by Roche and is included in three NDAs.

The generic ingredient in TARACTAN is chlorprothixene. Additional details are available on the chlorprothixene profile page.
Drug patent expirations by year for TARACTAN
Medical Subject Heading (MeSH) Categories for TARACTAN
Synonyms for TARACTAN
.alpha.-Chlorprothixene
(.alpha.-2-Chloro-9-.omega.-dimethylamino-propylamine)thioxanthene
(3-[2-CHLORO-THIOXANTHEN-(9Z)-YLIDENE]-PROPYL)-DIMETHYL-AMINE
(3E)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethyl-propan-1-amine
(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
(alpha.-2-Chloro-9-.omega.-dimethylamino-propylamine)thioxanthene
(Z)-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene
(Z)-2-Chloro-9-(omega-dimethylaminopropylidene)thioxanthene
(Z)-2-Chloro-N,(sup.gamma.)-propylamine
(Z)-2-Chloro-N,N-dimethylthioxanthene-.DELTA.(sup9),(sup.gamma.)-propylamine
(Z)-2-Chloro-N,N-dimethylthioxanthene-delta(sup 9,gamma)-propylamine
(Z)-3-(2-CHLORO-9H-THIOXANTHEN-9-YLIDENE)-N,N-DIMETHYL-1-PROPANAMINE
(Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
(Z)-3-(2-Chlorothioxanthen-9-ylidene)-NN-dimethylpropylamine
(Z)-chlorprothixene
[3-(2-CHLORO-9H-THIOXANTHEN-9-YLIDENE)PROPYL]DIMETHYLAMINE
{3-[(9Z)-2-CHLORO-9H-THIOXANTHEN-9-YLIDENE]PROPYL}DIMETHYLAMINE
{3-[2-Chloro-thioxanthen-(9Z)-ylidene]-propyl}-dimethyl-amine
1-Propanamine, 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-, (3Z)-
1-Propanamine,N-dimethyl-, (Z)-
113-59-7
113C597
2-Chloro-9-[.omega.-(dimethylamino)propylidene]thioxanthene
2-Chloro-9-[3-(dimethylamino)propylidene]thioxanthene
2-Chloro-N, .gamma.-propylamine
2-Chloro-N,N-dimethylthioxanthene-.delta.(sup 9), .gamma.-propylamine
3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-1-propanamine
3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
4695-61-8
58889-16-0
9S7OD60EWP
A8398
AB07571
AB2000283
AC1LDI5C
AKOS005065593
API0001973
BDBM50240514
Bio-0770
BRD-K81091703-003-01-0
C07953
C3505
CCG-36988
CHEBI:50931
CHEMBL908
Chloroprothixene
Chlorprothixen
chlorprothixene
Chlorprothixene (JAN/USAN/INN)
Chlorprothixene [USAN:INN:BAN:JAN]
Chlorprothixene [USAN:USP:INN:BAN:JAN]
Chlorprothixenum
Chlorprothixenum [INN-Latin]
Chlorprotixen
Chlorprotixene
CHLORTHIAXANTHENE
Chlothixen
chorprothixene
cis-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene
cis-Chlorprothixene
Clorprotisene
Clorprotisene [DCIT]
Clorprotixeno
Clorprotixeno [INN-Spanish]
Cloxan
Cloxan, Taractan, Truxal, Chlorprothixene
Cloxan;Taractan;Truxal
CS-2264
D00790
D0B0CP
EINECS 204-032-8
EN300-119498
HMS2788N19
HSDB 2808
HY-B0274
Iaractan
J-002997
KS-5102
MK 184
MLS000768404
MolPort-002-590-309
N 714
N 714C
N-714
NCGC00166133-01
NCI56378
NE11732
NSC 18720
NSC-18720
NSC18720
NSC56379
Paxyl
PDSP1_001124
PDSP2_001108
PL005904
PL041984
Prestwick2_000348
Rentovet
Ro 4-0403
Ro-4-0403
Ro-40403
s1771
SC-79175
SCHEMBL94235
SCHEMBL94236
SMR000431796
STK545163
Tactaran
Taractan (TN)
Tarasan
Tardan
Thioxanthene-.delta.(sup 9), 2-chloro-N,N-dimethyl-
Thioxanthene-.DELTA.9, 2-chloro-N,N-dimethyl-, (Z)-
Thioxanthene-delta(sup 9),gamma-propylamine, 2-chloro-N,N-dimethyl-, (Z)-
Thioxanthene-delta9,gamma-propylamine, 2-chloro-N,N-dimethyl-, (Z)- (8CI)
Thioxanthene-delta9,gamma-propylamine, 2-chloro-N,N-dimethyl-, (Z)-(8CI)
trans(E)-Chlorprothixen
Traquilan
Trictal
Truxal
Truxal (TN)
Truxaletten
Truxil
UNII-9S7OD60EWP
Vetacalm
WLN: T C666 BS IYJ FG IU3N1 & 1
ZINC1137

US Patents and Regulatory Information for TARACTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche TARACTAN chlorprothixene CONCENTRATE;ORAL 016149-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche TARACTAN chlorprothixene INJECTABLE;INJECTION 012487-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Accenture
Baxter
Express Scripts
QuintilesIMS
Farmers Insurance
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.